<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210728052005N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-06</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Comparative Investigating the effect of the Auricolotherapy and mindfulness-based stress reduction counseling on the nausea and vomiting of pregnancy in pregnant women</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Investigating the effect of the Auricolotherapy and mindfulness-based stress reduction counseling on the nausea and vomiting of pregnancy in pregnant women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-09-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>159</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57891</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Because people enter the study over time, the blocking method of blocking is used. Which is used from statistical software. Because the three groups are in this study, six blocks are used, Blinding description: In order to be blind, the statistical analyst would be unaware of which group the subjects belonged to.</study_design>
      <phase>N/A</phase>
      <hc_freetext>nausea and vomiting of pregnancy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Auriculotherapy .In the intervention group with Auriculotherapy, in addition to routine prenatal care and medication, for three consecutive weeks, every three to five days, Wakaria sids are attached to specific points (mouse, esophagus and master shoulder) of the mother's right ear. He is asked to press the labeled points five to six times a day for 60 seconds each time by applying pressure with his fingers. Intervention 2: Intervention group: Mindfulness-based stress reduction counseling. In the counseling intervention group with a Mindfulness-based stress reduction approach, individuals will undergo six two-hour face-to-face sessions for three weeks (two sessions per week). It is noteworthy that due to the prevalence of Covid-19 disease and the importance of maintaining the health of pregnant women, if the conditions are not favorable until the intervention, counseling sessions will be taught virtually using the Skyroom training platform. Intervention 3: Control group: Routine Pregnancy Care. In the control group, while receiving routine pregnancy care, considering the ethical aspect of the research, it will be possible to use anti-nausea pills up to three times a day. It is important to note that the list will be provided to the mother and she will be asked to write down the name of the drug and its dosage to report to the researcher if she is taking a pill or treatment to reduce nausea and vomiting.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After the study, some information such as information about gestational age, the severity of vomiting nausea can be shared. More definite decisions will be made with the tutor.

When:
Access period starts 6 months after the results are published

To whom:
After reading and printing the results, everyone will have access

Conditions:
The use of research results by mentioning the names of the facilitator and colleagues for use in future studies will be allowed.

Where to obtain:
zahrakashfi71@yahoo.com
00989124332581 zahra kashfi

How to obtain:
Up to one month after the request, the authorized information will be sent to the person

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>zahra kashfi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 5, Next to the Department of EducationLar, Shahr Jadid</address>
        <city>Lar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7431715544</zip>
        <telephone>+98 71 5224 5533</telephone>
        <email>m.ghazanfarpour@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Masumeh Ghazanfarpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus, Haft Bagh Highway, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5219</telephone>
        <email>m.ghazanfarpour@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having the gestational age of the last 6-16 weeks on the first day of the last menstrual period.
Mild or moderate vomiting nausea based on Rhodes index (score 8-24)
Having complete physical and mental health (absence of gastrointestinal, heart or other underlying diseases)
4. Literacy to the extent of reading and writing
5. Having a single, normal, live, uncomplicated pregnancy and maintaining it until the end of the study
6. Women in the age range of 18 to 35 years
7. Willingness to participate in the study
8. Failure to use drugs that may be subjected to nausea and vomiting. Like: Metronidazole.
9. Mole pregnancy is ruled out by ultrasound.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>1) Loss of pregnancy
2) Reluctance to continue to participate in the study
3) Hospitalization due to the transformation of the disease into a severe form of hypermesis gravidarum
4) Having any gastrointestinal disease or any disorder that leads to an abnormal increase in blood HCG levels ( Twins)
5) Using other methods to treat nausea and vomiting in pregnancy, except anti-nausea pills</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Auriculotherapy .In the intervention group with Auriculotherapy, in addition to routine prenatal care and medication, for three consecutive weeks, every three to five days, Wakaria sids are attached to specific points (mouse, esophagus and master shoulder) of the mother's right ear. He is asked to press the labeled points five to six times a day for 60 seconds each time by applying pressure with his fingers.</i_keyword>
      <i_keyword>Intervention group: Mindfulness-based stress reduction counseling. In the counseling intervention group with a Mindfulness-based stress reduction approach, individuals will undergo six two-hour face-to-face sessions for three weeks (two sessions per week). It is noteworthy that due to the prevalence of Covid-19 disease and the importance of maintaining the health of pregnant women, if the conditions are not favorable until the intervention, counseling sessions will be taught virtually using the Skyroom training platform.</i_keyword>
      <i_keyword>Control group: Routine Pregnancy Care. In the control group, while receiving routine pregnancy care, considering the ethical aspect of the research, it will be possible to use anti-nausea pills up to three times a day. It is important to note that the list will be provided to the mother and she will be asked to write down the name of the drug and its dosage to report to the researcher if she is taking a pill or treatment to reduce nausea and vomiting.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Rhodes Nausea and Vomiting Questionnaire score. Timepoint: Rhodes questionnaire score was measured before the intervention, immediately after the intervention and two weeks after the intervention. Method of measurement: Rhodes Nausea and Vomiting Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-28</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Kerman University of Medical Sciences ,Medical University Campus ,Haft Bagh Highway ,Kerman ,Iran Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
